当前位置: 首页 > 期刊 > 《中国现代医生》 > 2018年第7期
编号:13235631
真菌(1,3)—β—D—葡聚糖检测在早期诊断ICU肺侵袭性真菌感染中的临床价值(4)
http://www.100md.com 2018年3月5日 《中国现代医生》 2018年第7期
     [17]鄭罡,余进,李雪迎,等.(1,3)-β-D-葡聚糖检测和半乳甘露聚糖抗原检测在侵袭性真菌病诊断中的价值探讨[J].中国真菌杂志,2012,7(3):132-135.

    [18]Hanson KE,Pfeiffer CD,Lease ED,et al.β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients:A randomized pilot study[J].PLOS One,2012,7(8):e42282.

    [19]Held J,Wagner D. β-D-Glucan kinetics for the assessment of treatment response in Pneumocystis jirovecii pneumonia[J]. Clin Microbiol Infect,2011,17(7):1118-1122.

    [20]Michael Ellis,Basel al-Ramadi,Malcolm Finkelman,et al. Assessment of the clinical utility of serial β-D-glucan concentrations in patients with persistent neutropenic fever[J]. Journal of Medical Microbiology,2008,57(3):287-295.

    [21]Giacobbe DR,Esteves P,Bruzzi P,et al.Initial serum(1,3)-β-d-glucanasa predictor of mortality in proven candidaemia:Findings from a retrospective study in two teaching hospitals in Italy and Brazil[J].Clinical Microbiology and Infection,2015,21(10):e9-17.

    (收稿日期:2017-11-27), 百拇医药(汪艳 沈翠芬 夏森林)
上一页1 2 3 4